HCA vs TERN · P/E 17, rev $75.60B vs $6.12B cap
HCA Holdings Inc (HCA) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
HCA currently screens at market cap $91.01B and trailing P/E 16.8. TERN currently screens at market cap $6.12B.
Not investment advice. Open the HCA and TERN stock pages for the full models.
Not investment advice.